Skip to main content
. 2017 Sep 1;9(3):185–193. doi: 10.4274/jcrpe.3873

Table 2. Comparison of type of treatment, outcome, and presence of BRAFV600E mutation in prepubertal and pubertal patients after excluding microcarcinoma.

graphic file with name JCRPE-9-185-g2.jpg